Show
Sort by
-
Short course chemotherapy followed by concomitant chemoradiotherapy and surgery in locally advanced rectal cancer: a randomized multicentric phase II study
-
Feasibility of radiotherapy with concomitant gemcitabine and oxaliplatin in locally advanced pancreatic cancer and distal cholangiocarcinoma: a prospective dose finding phase I-II study
-
Dose-finding study using oxaliplatin in combination with fixed dose gemcitabin and radiotherapy in patients with locally advanced pancreatic or biliary tract cancer.
-
Gemcitabine and oxaliplatin (GEMOX) in gemcitabine refractory advanced pancreatic adenocarcinoma: a phase II study
-
Adjuvant gemcitabine and concurrent continuous radiation (45 Gy) for resected pancreatic head carcinoma: A multicenter Belgian Phase II study
-
Gemcitabine and oxaliplatine (GEMOX) in gemcitabine-refractory advanced pancreatic cancer: a phase II study
-
Raltitrexed plus Gemcitabine (TOMGEM) in advanced pancreatic cancer - Results of a Belgian Multicentre Phase II Study
-
Adjuvant gemcitabine (GEM) and concurrent continuous radiation (45 Gy) for resected pancreatic head carcinoma: a multicenter belgian phase II study
-
Raltitrexed/gemcitabine in patients with advanced biliary tract adenocarcinoma: a phase II study